脑啡肽酶
化学
亚胺
酶
生物化学
还原酶
组合化学
催化作用
磷酸西他列汀
立体化学
生物
2型糖尿病
糖尿病
内分泌学
作者
Xiang Yi,Florian Kleinbeck,Charlene Ching,Lorita Boghospor,Sandy Gomes,Oscar Alvizo,Thomas Allmendinger,Jason S. Fell,Nandhitha Subramanian,Michelle Li,Ravi Garcia,James N. Riggins,David A. Entwistle,Yvonne Richter,Daniel A. Gschwend,Liam Lauener,Thomas S. Peat,Hélène Lebhar,Thierry Schlama,Thomas Ruch
标识
DOI:10.1021/acscatal.3c05615
摘要
Imine reductases (IREDs) have been identified as an important class of biocatalysts to synthesize chiral amines with substantial promise for industrial application. Here, we report the promiscuous imine reductase activity of a glucose dehydrogenase (GDH). Starting from enzyme GDH Rd1bb, a commercial glucose dehydrogenase variant typically used for NAD(P)H regeneration, eight rounds of directed evolution were used to convert this enzyme into a highly active IRED for the chemo- and stereoselective manufacture of a chiral neprilysin inhibitor precursor, improved NADH cofactor specificity, and superior thermal stability. The evolved variant GDH Rd6bb achieved high productivity, with 99% conversion over 3 h at 50 g/L keto substrate concentration and 10% enzyme loading with respect to the keto substrate. Early process development studies at multigram scale provided the product in 94% yield with >99% purity as a single stereoisomer with an er of >99.9:0.1 and a dr of >99.9:0.1.
科研通智能强力驱动
Strongly Powered by AbleSci AI